Ahmed Elkhanany, MD discusses unmet needs in patients with estrogen receptor–positive breast cancer who progress on frontline therapy, treatment considerations for these patients, and how FES PET imaging may benefit this population.
Ahmed Elkhanany, MD, discusses biological drivers of disease in patients with estrogen receptor–positive breast cancer who have disease progression shortly after initiating first-line therapy, as well as the importance of performing comprehensive genetic testing in these patients to determine subsequent treatment approaches.
Breast Cancer Research Foundation of Alabama exceeds $1 2 million investment in Alabama-based research alabamanewscenter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alabamanewscenter.com Daily Mail and Mail on Sunday newspapers.
BCRFA invests over $1 million into research projects in 2020 - Birmingham Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.